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HCV culture in vitro results in massive cell death, which suggests the presence of HCV-induced cytopathic effects. Therefore, we investigated
its mechanisms and viral nucleotide sequences involved in this effect using HCV-JFH1 cell culture and a newly developed HCV plaque assay
technique. The plaque assay developed cytopathic plaques, depending on the titer of the inoculum. In the virus-infected cells, the ER stress
markers, GRP78 and phosphorylated eIF2-alpha, were overexpressed. Cells in the plaques were strongly positive for an apoptosis marker, annexin
V. Isolated virus subclones from individual plaque showed greater replication efficiency and cytopathogenicity than the parental virus. The plaque-
purified virus had 9 amino acid substitutions, of which 5 were clustered in the C terminal of the NS5B region. Taken together, the cytopathic effect
of HCV infection involves ER-stress-induced apoptotic cell death. Certain HCV genomic structures may determine the viral replication capacity
and cytopathogenicity.
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Molecular analyses of the HCV life cycle, virus–host
interactions, and mechanisms of liver cell damage by the virus
are not understood completely, mainly because of the lack of cell
culture systems. These problems have been partly overcome by
the development of the HCV subgenomic replicon (LohmannAbbreviations: HCV, hepatitis C virus; IFN, interferon; CPE, cytopathic
effect; ER, endoplasmic reticulum; UPR, unfolded protein response; PFU,
plaque-forming unit; FFU, focus-forming unit; RdRp, RNA-dependent RNA
polymerase.
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doi:10.1016/j.virol.2007.09.019et al., 1999) and HCV cell culture systems (Lindenbach et al.,
2005; Wakita et al., 2005; Zhong et al., 2005). The HCV-JFH1
strain, which is a genotype 2a clone derived from a Japanese
fulminant hepatitis patient that can replicate efficiently in Huh7
cells (Kato et al., 2003; Kato et al., 2001), has contributed to the
establishment of the HCV cell culture system. Furthermore, the
Huh7-derived cell lines, Huh-7.5 cells, Huh-7.5.1, and Lunet
cells allow production of higher viral titers and have a higher
permissiveness for HCV (Koutsoudakis et al., 2007; Lindenbach
et al., 2005; Zhong et al., 2005). The HCV-JFH1 cell culture
system now allows us to study the complete HCV life cycle:
virus–cell entry, translation, protein processing, RNA replica-
tion, virion assembly, and virus release.
HCV belongs to the family Flaviviridae. One of the char-
acteristics of the Flaviviridae is that they cause cytopathic
effects (CPE). The viruses have positive strand RNA genomes of
∼10 kilobases that encode a polyprotein of∼3000 amino acids.
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proteases into at least 10 mature proteins. The viral nonstructural
proteins accumulate in the ER and direct genomic replication
and viral protein synthesis (Bartenschlager and Lohmann, 2000;
Jordan et al., 2002;Mottola et al., 2002). It has been reported that
Japanese encephalitis virus (JEV), bovine viral diarrhea virus
(BVDV), and dengue viruses (DEN) cause apoptotic cell death
(Despres et al., 1996; He, 2006; Jordan et al., 2002; Su et al.,
2002). In addition, certain amino acid substitutions in the viral
structural or nonstructural proteins affect the replication and
cytopathogenicity of these viruses substantially (Blight et al.,
2000; Maekawa et al., 2004; Mendez et al., 1998). It has been
recently reported that HCV-JFH1-transfected Huh-7.5.1 cells
died when all of the cells were infected and intracellular HCV-
RNA reached maximum levels (Zhong et al., 2006). These
findings suggest HCV-induced cytopathogenicity. However, the
mechanisms have not been well documented.
In the present study, we investigated the cellular effects of
HCV infection and replication using the HCV-JFH1 cell culture
system. Here, we report that HCV-JFH1-transfected and in-
fected cells show substantial CPE that are characterized by
massive apoptotic cell death with the expression of several ER
stress-induced proteins. Taking advantage of the CPE, we
developed a plaque assay for HCV in cell culture and isolated
subclones of HCV that showed enhanced replication and cyto-
pathogenicity. We have demonstrated that these viral characters
were determined by mutations at certain positions in the struc-
tural and nonstructural regions of the HCV genome, especially
the NS5B region.Fig. 1. Replication of HCV-JFH1 RNA in JFH1-transfected and infected Huh-7.5.1 c
of the in vitro transcribed JFH1-RNA into Huh-7.5.1 cells, total cellular RNAwas is
culture supernatant of JFH1-RNA transfected Huh-7.5.1 cells was collected on the
measured (black bar). (B) HCV-JFH1-transfected Huh-7.5.1 cells (the left panel, daResults
Production of infectious HCV-JFH1 by JFH1-RNA transfected
cells
After transfection of HCV-JFH1 RNA into Huh-7.5.1 cells,
intracellular HCV RNA and HCV antigen were continuously
detectable in the cell culture (Fig. 1A). Furthermore, the culture
supernatant from the transfected cells was positive for core
protein, which reached maximum levels at 14 days post-trans-
fection and was continuously detectable during the cell culture
(Fig. 1A, black bar). The culture supernatant was readily in-
fectable to naive Huh-7.5.1 cells (data not shown). Immunoflu-
orescence assay showed that 48% of the JFH1-RNA-transfected
cells and 42% of the virus-infected cells were positive for HCV
core protein. These results demonstrate that the transcript of
HCV-JFH1 clone replicates efficiently and produces infectious
virus particles in cells, as reported previously (Wakita et al.,
2005; Zhong et al., 2005).
Hepatitis C virus infection induced cytopathic effects in vitro
By the seventh day post-transfection, the production of virus
decreased concomitant with massive cell death and then cell
growth gradually recovered. At 14–16 days post-transfection,
the levels of HCV-RNA and core antigen reached maximum
(Fig. 1). In the JFH1 mutants JFH1/GND and JFH1/ΔE1-E2-
RNA-transfected Huh-7.5.1 cells, the viral replication and host
cell death were not observed. The massive cell death after HCV-ells. (A) Levels of HCV-RNA in JFH1 RNA-transfected cells. After transfection
olated on indicated days and quantified by real-time RT-PCR. Furthermore, the
days indicated and the levels of core antigen in the culture supernatant were
y 0; the middle panel, day 6; the right panel, day 16).
73Y. Sekine-Osajima et al. / Virology 371 (2008) 71–85JFH1 transfection led us to suspect the occurrence of CPE,
produced in host cells by HCV infection and replication. A
plaque assay was performed (see Materials and methods) toFig. 2. The cytopathic effects of HCV-JFH1 in vitro. (A) Plaque assay. Upper panel, H
of 4×105 cells per plates and were incubated at 37 °C under 5.0% CO2 (as describ
serially diluted in a final volume of 2 ml per plates and transferred onto the cell mono
were overlaid with 8 ml of culture medium containing 0.8% methylcellulose and in
plaque was visualized by staining with 0.08% crystal violet solution. Lower panel, J
presence of 50 U/ml interferon-alpha. JFH1+a-CD81, Huh-7.5.1 cells were pretreate
anti-CD81 was removed, the cells were washed with PBS, and the HCV-JFH1 culture
and the infected cells were overlaid with 8 ml of culture medium containing 0.8%meth
GND or JFH1/ΔE1-E2 culture supernatant. (B) The cytopathic plaques were observinvestigate the morphological CPE following HCV-JFH1
infection. Culture supernatants from JFH1-transfected cells
were diluted serially and inoculated onto uninfected Huh-7.5.1uh-7.5.1 cells were seeded in collagen-coated 60-mm-diameter plates at density
ed above). After overnight incubation, HCV-infected culture supernatants were
layers. After ∼5 h of incubation, the inocula were removed and the infected cells
cubated under normal conditions. After 7 days culture, formation of cytopathic
FH1+IFN; after infection of the virus supernatant, the cells were cultured in the
d with 10 μg/plate of anti-CD81 antibody. After incubation at 37 °C for 30 min,
supernatant was transferred. After∼5 h incubation, the supernatant was removed
ylcellulose and controls for the plaque assay were also performed with the JFH1/
ed by phase-contrast microscopy at day 7 after HCV-JFH1 infection.
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taining agarose. Almost 10 days after the inoculation, viable
cells were stained and plaques were visualized (Fig. 2A, upper
panel). HCV-inoculated cell cultures developed plaques as
unstained areas that were accompanied by round cells in the
periphery (Fig. 2B). The formation of cytopathic plaques was
not observed in a parental Huh7 cell line (data not shown).
Immunocytochemistry of the foci revealed the presence of
HCV core-positive cells surrounding the cytopathic plaques
(Fig. 3A). Culture of the HCV-inoculated cells in the presence
of interferon-alpha (50 U/ml) completely abolished the
formation of plaques (Fig. 2A, lower panel). Uninfected Huh-
7.5.1 cells (Fig. 2A, upper panel), Huh-7.5.1 cells treated with
anti-CD81 antibody before HCV-JFH1 infection and JFH1/
GND or JFH1/ΔE1-E2-transfected cell cultures did not develop
plaques (Fig. 2A, lower panel). These findings suggest that
HCV-infected cells develop cytopathic plaques depending on
the quantity of the inoculums and that HCV replication, viral
protein expression and the propagation of viral particles were
the features of these plaques.Fig. 3. Immunofluorescence detection of HCV core protein in cytopathic plaques. (A
cells, plated on 22mm-roundmicro cover glasses in 60-mm-diameter plates at density
medium containing 0.8% methylcellulose. Immunocytochemistry was performed 12 d
detection of HCV-positive foci and cytopathic plaques. The HCV-JFH1 culture super
∼5 h incubation, the supernatant was removed and the infected cells were cultu
Immunocytochemistry was performed 5 days after infection using mouse anti-core ant
foci (FFU/ml) and cytopathic plaque (PFU/ml) respectively. White arrowheads indicHCV-JFH1 infection induced host-cell apoptosis
We next determined whether the cytopathic effects of HCV-
JFH1 replication include process of apoptotic cell death. Cells
including plaques were double-stained with annexin V-FITC
and PI. The ligand of annexin V, phosphatidylserine, is nor-
mally confined to the cytoplasmic leaflets of the plasma mem-
brane. In the early phase of apoptosis, phosphatidylserine is
exposed on the outer surface of the plasma membrane, which
enables detection of FITC-labeled annexin V. As shown in
Fig. 4, the fluorescence of annexin V was observed in the cells
around the plaques. Foci of apoptotic cells were scattered in the
plaques. On the other hand, the expression of annexin V was
slightly detectable in the subgenomic replicon-harboring cells,
though they were at the same level as the uninfected Huh-7.5.1
cells and the cell death was not observed. Therefore, the cells
that express HCV subgenomic replicons did not induce apo-
ptotic cell death. These findings demonstrate that the cytopathic
effects of HCV replication and the particle formation induce
apoptotic cell death.) The HCV-JFH1 culture supernatant was transferred onto uninfected Huh-7.5.1
of 2×105 cells per plate. After∼5 h incubation, the supernatant was replacedwith
ays after infection. A ‘P’ indicates a cytopathic plaque. (B) Immunofluorescence
natant was transferred at various dilutions onto uninfected Huh-7.5.1 cells. After
red in 60-mm-diameter plate with medium containing 0.8% methylcellulose.
ibody. The infectivity and cytotoxicity were quantified by counting HCV-positive
ate HCV-positive foci.
Fig. 4. HCV-JFH1 infection induces apoptosis and leads to plaque formation. The HCV-JFH1 culture supernatant was transferred onto uninfected Huh-7.5.1 cells
plated on 22-mm round micro cover glasses in 60-mm-diameter plates at density of 2×105 cells per plate. After ∼5 h incubation, the supernatant was replaced with
medium containing 0.8% methylcellulose. Thirteen days after infection, cover glasses were incubated with 100 μl of staining solution containing Annexin V-FITC at
room temperature for 10 to 15 min. The cells that express HCV subgenomic replicons were also incubated and stained with Annexin V-FITC. Rep 1b, Rep-Feo; Rep
2a, SGR-JFH1 (see Materials and methods).
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proteins
Cellular stresses such as virus infections prevent protein
folding and maturation in the endoplasmic reticulum (ER) and
result in the accumulation of misfolded proteins (ER stress)
(Kaufman, 1999; Pahl, 1999), triggering the unfolded protein
response (UPR). The UPR leads to global shut-off of protein
translation and to apoptotic cell death (Ferri and Kroemer, 2001;
Mori, 2000; Munro and Pelham, 1986). We and other groups
have previously reported that subgenomic or genomic HCV
replication induces ER stress and triggers UPR (Nakagawa
et al., 2005; Tardif et al., 2002). Therefore, we next studied
expression of the ER stress-related proteins, GRP78 and
phosphorylated eIF2-alpha, in JFH1-infected cells (Fig. 5).
GRP78 is one of the ER chaperones whose expression is
induced by ER stress through cleavage and nuclear transloca-
tion of ATF6. The eIF2-alpha is phosphorylated by PER-likeER kinase (PERK) on ER stress, causing direct global inhibition
of initiation of protein translation (Harding et al., 1999). Huh-
7.5.1 cells were infected with HCV-JFH1 supernatant and
harvested on the fourth and seventh days post-infection (Fig. 5).
As the expression of HCV core protein increased, expression
levels of GRP78 and phosphorylated eIF2-alpha also increased
substantially. Suppression of virus replication by interferon-
alpha treatment led to a decrease of cellular GRP78 and
phosphorylated eIF2-alpha. Interferon-alpha treatment did not
eliminate the expression of HCV completely, though the levels
of core and phosphorylated eIF2-alpha expression apparently
decreased compared with the JFH-1 infected Huh-7.5.1 cells at
seventh days post-infection. These findings demonstrated that
HCV-JFH1 infection induced ER stress.
Persistence of ER stress activates apoptosis signaling path-
ways, including the induction of C/EBP homologous protein
(CHOP) and activation of JNK kinase and caspase12, leading to
cell death (Ferri and Kroemer, 2001). As shown in Fig. 5, the
Fig. 5. Expression of ER stress-related proteins in HCV-JFH1 infected cells. The
supernatant of JFH1-transfected Huh-7.5.1 cells was transferred onto uninfected
Huh-7.5.1 cells. The cells were harvested at 4 and 7 days after infection. The
JFH1-infected cells were also cultured with interferon (50 U/ml) or 2-
mercaptoethanol (0.2 μg/ml) and harvested after 48 h after treatment. 2-
Mercaptoethanol was used as a positive control to induce ER stress (Nakagawa
et al., 2005). Western blotting was performed using anti-core, anti-GRP78, anti-
phospho-eIF2-alpha (p-eIF2α), anti-eIF2-alpha, anti-GADD153/CHOP, and
anti-beta-actin antibodies. β-ME, 2-mercaptoethanol.
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infected Huh-7.5.1 cells.
To determine whether ER stress contributes to the formation
of cytopathic plaques, JFH1-infected cells were incubated in
methylcellulose-containing medium and double immunofluo-
rescence staining of the plaques was performed. As shown in
Fig. 6, overexpression of GRP78 was colocalized with HCV-
core-positive cells with and without CPE. Together with the
result shown in Fig. 4, these findings suggest that ER stress is
induced in the HCV-JFH1-infected cells and these responses
may be involved in development of apoptosis and the formation
of cytopathic plaques.
A cytopathic clone could be isolated and this had acquired a
high infection efficiency and increased cytopathogenicity
The plaque assay enabled differential quantification of viral
infectivity and cytopathogenicity by the immunofluorescence
detection of HCV core protein in JFH1-infected, plaque-
developed cultures. The number of plaques, as well as
infectious foci, was linearly proportional to the dilution of an
inoculum (Fig. 7B). It was revealed that only a few populationsof HCV-positive foci developed cytopathic plaques (Fig. 3B
and Table 1). The infectious focus-forming units and plaque-
forming units were 5.6×103 FFU/ml and 9.7×102 PFU/ml,
respectively (Table 1).
To determine whether the difference between the cytopathic
and noncytopathic HCV-JFH1 replication might be attributable
to viral factors, we isolated clones from each cytopathic plaque.
JFH1-infected Huh-7.5.1 cells were incubated in DMEM
containing methylcellulose. Cytopathic plaques became visible
at ∼1 week after inoculation. We isolated cells from each
plaque using a cloning cylinder, subcultured, and transferred
supernatant onto uninfected Huh-7.5.1 cells. To our surprise,
infection of naive cells with plaque-derived supernatants led to
massive cell death at 10 days post-infection (Fig. 8A). The
supernatant of these cells was transferred again onto uninfected
Huh-7.5.1 cells again. Immunofluorescence assay revealed that
almost 100% of the cells were positive for HCV core protein
(Fig. 8B). The infectivity and cytopathogenicity of this isolated
plaque (Pl #1) were 4.9×103 FFU/ml and 3.0×103 PFU/ml
respectively (Table 1), much higher than the parental JFH1
clone. Moreover, the ratio of PFU to FFU in a plaque-isolated
clone (Pl #1) was significantly higher than that of parental JFH1
clone (0.58 and 0.17 respectively) (Table 1 and Figs. 7B and C).
We next performed an infection experiment of the parental
JFH1 and a plaque-derived clone by adjusting infectious titers
of the inocula by HCV core antigen levels. As shown in Fig. 8C,
virus from cytopathic plaque (Pl #1, #2, #3) showed signif-
icantly higher elevation of core antigen levels in supernatants
than the parental JFH1 in every time point. The second round
isolation of plaques from the Pl #1 subclone (Pl #1-1, #1-2 and
#1-3 in the Table 3) showed consistently higher replication
efficiency and cytopathogenicity. These results indicated that
JFH1 subclones isolated from cytopathic plaques showed sig-
nificantly higher infection efficiency and greater cytopathic
effects than the original JFH1.
The isolated plaque had amino acid substitutions clustered in
the NS5B region
To determine whether there are viral mutations in the cyto-
pathic JFH1 subclone (Pl #1), we performed sequence analyses.
As shown in Table 2, 11 nucleotide changes were found in the
cytopathic plaque, and 9 of these were non-synonymous
mutations (81.8%). In particular, 6 of the 11 mutations (9153,
9232, 9293, 9295, 9353, and 9355) were clustered in the C
terminal half of the NS5B region. We also performed sequence
analyses of the Pl #1-isolated subclones, Pl #1-1, #1-2, and #1-
3, and other clones that had been independently isolated from
different plaques, Pl #2, #3, and #4 (Table 3). Those subclones
showed similar mutations within NS5B region. The C2438S,
P2934S, and S3001N substitutions were redundantly appeared
in the 4 plaque-isolated clones and in all three Pl #1-derived
subclones. In contrast, no mutations were found in the virus
from infectious foci without plaque formation. These results
showed an evidence that certain amino acid mutations were
directly associated with the viral replication efficiency and
cytopathogenicity.
Fig. 6. Co-expression of HCV core and GRP78 in the cytopathic plaque. The HCV-JFH1 culture supernatant was transferred onto uninfected Huh-7.5.1 cells plated on
22-mm round micro cover glasses in 60-mm-diameter plates at density of 4×105 cells per plate. After ∼5 h incubation, the supernatant was replaced with medium
containing 0.8% methylcellulose. Double immunofluorescence was performed 10 days after infection using mouse anti-core antibody and goat-anti-GRP78 antibody.
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replication efficiency and cytopathogenicity
We finally investigated on phenotypes of the amino acid
mutations identified in the isolated cytopathic subclones. We
constructed mutant clones from the wild type JFH1 plasmid, in
which three amino acid mutations in NS5B region were
individually introduced; T7662A, C9153T, and G9295C (see
Tables 2 and 3). Transfection of the mutant HCV-RNAs showed
that all mutants developed massive cell death on 10 days after
transfection and that their extents of the CPE were apparently
greater than the wild type JFH1 clone (Fig. 9A). The levels of
core antigen in the culture medium were significantly higher in
the mutant clones than in the wild type (Fig. 9B). Furthermore,
the expression levels of cellular HCV core protein were
significantly higher in the mutant clones than in the wild type
with the order of T7662NC9153≫G9295CNJFH1 (Fig. 9C).
Discussions
Our results show that replication of HCV-JFH1 resulted in
morphologic changes to the host cells, which are characterized
by massive cell death (Figs. 1–3). These observations sug-
gested that HCV infection and replication could cause CPE on
the host cells. The development of the CPE involved virus
protein-induced ER stress and subsequent apoptotic cell death
(Figs. 4–6). The JFH1/ΔE1-E2 with deletion of the HCVenvelope proteins-infected Huh-7.5.1 cells did not induce the
CPE (Fig. 2A), which indicates that the key factors of plaque
formation are not only viral replication but also the propagation
of virus particles and re-infection. We took advantage of the
HCV-induced CPE and developed a plaque assay using highly
permissive Huh-7.5.1 cells. The assay revealed that the HCV-
induced cytopathogenicity varied between infectious foci with
cytopathic and noncytopathic infection (Fig. 3B). Interestingly,
isolated JFH1 subclones from the plaques showed significantly
increased infectivity and cytopathogenicity (Table 1 and Fig. 8).
Viral genetic analyses showed nine amino acid substitutions;
among them five were clustered in the C terminal half of the
NS5B region, which might contribute to virus replication effi-
ciency and cytopathogenicity (Table 2).
Cytopathic effects are key characteristics of the Flaviviridae
that include Japanese encephalitis virus (JEV) (Vaughn and
Hoke, 1992), West Nile Virus (Borisevich et al., 2006), yellow
fever virus (Quaresma et al., 2006), dengue virus (DEN) (Des-
pres et al., 1993), and bovine viral diarrhea virus (BVDV)
(Mendez et al., 1998) and also of viruses such as adenovirus
(Shinoura et al., 1999), Epstein–Barr virus (Sato et al., 1989),
poliovirus (Yanagiya et al., 2005), and influenza virus (Hinshaw
et al., 1994). The Flaviviridae utilizes the ER as the primary site
for genomic replication and protein synthesis (Jordan et al.,
2002; Su et al., 2002; Tardif et al., 2004). It has been reported
that apoptotic cell death mediated by virus-induced ER stress
contributes to the cytotoxicity of JEV, BVDV, and DEN-2
Fig. 7. Correlation of infectious foci or plaques with dilution of an inoculum. (A) Plaque assay. Huh-7.5.1 cells were seeded in collagen-coated 60-mm-diameter plates
at density of 4×105 cells per plates and were incubated at 37 °C under 5.0% CO2. After overnight incubation, HCV-JFH1 (left panel) or plaque-purified clone (Pl #1)
(right panel) infected culture supernatants were serially diluted in a final volume of 2 ml per plates and transferred onto the cell monolayers. After ∼5 h of incubation,
the inocula were removed, and the cell monolayers were overlaid with 8 ml of culture medium containing 0.8% methylcellulose. After 7 days of culture under normal
conditions, formation of cytopathic plaque was visualized by staining with 0.08% crystal violet. (B and C) The PFU-adjusted culture supernatant of parental HCV-
JFH1 (B) or plaque-purified clone (Pl #1) (C) was transferred at various dilutions onto uninfected Huh-7.5.1 cells, and the plaque assay and immunocytochemistry
were performed (described above). The infectivity and cytotoxicity were quantified by counting HCV-positive foci and cytopathic plaque respectively. The horizontal
axis showed dilutions of the viral supernatant and the vertical axis showed the number of infectious foci or plaques.
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infected cells, the NS2B-3 protein causes XBP1 splicing and
induces ER stress (Yu et al., 2006). These findings are consistent
with our results for HCV in that the JFH1 infection induced ER
stress and unfolded protein responses and led to apoptotic cell
death and formation of plaques.
The ER is closely associated with viral replication and
assembly. Most of the HCV structural and nonstructural pro-
teins accumulate in the ER membrane and form a membranous
web that is characterized by a convoluted ER structure (Gosert
et al., 2003). Moreover, the folding and assembly of HCVTable 1
Cytopathogenicity and infectivity of JFH1 clones
PFU/ml a FFU/ml b PFU/FFU
JFH1 9.7±3.8×102 c 5.6±0.9×103 0.17±0.05
Pl #1 3.0±1.9×103 4.9±1.6×103 0.58±0.21
a PFU, plaque-forming unit.
b FFU, focus-forming unit.
c Values are displayed as mean±S.D.proteins require interaction with ER chaperone proteins such as
calreticulin, BiP/GRP78, and heat shock protein-90 (HSP90)
(Choukhi et al., 1998; Waxman et al., 2001). The ER stress,
which is induced by virus replication, involves three different
mechanisms (Tardif et al., 2002): transcriptional induction,
translational attenuation, and protein degradation. In our study,
both GRP78 and phosphorylated eIF2-alpha proteins were
induced as viral proteins increased in concentration in HCV-
JFH1 infected cells, and the GRP78 or annexin Vand HCV core
proteins co-localize in cytopathic plaques, showing that HCV
infection and replication induce UPR and that ER stress-
mediated apoptosis causes the viral cytopathic effects on host
cells.
Several HCV structural and nonstructural proteins are
involved in the ER stress. The structural glycoproteins, E1
and E2, interact with ER chaperones (Choukhi et al., 1998;
Liberman et al., 1999), HCV NS4B induces UPR through ATF6
or the IRE1-XBP1 pathway (Zheng et al., 2005), and HCV core
triggers apoptosis by inducing ER stress and ER calcium
depletion both in vitro and in vivo (Benali-Furet et al., 2005).
Fig. 8. The isolation of cytopathic plaques. TheHCV-JFH1 culture supernatant was transferred at various dilutions onto uninfected Huh-7.5.1 cells. After∼5 h incubation,
the supernatant was removed then infected cells were cultured in 0.8%methylcellulose-containingmedium in 60-mm-diameter plates. Cytopathic plaques were detectable
at 8 days after infection. Cells from each plaque were isolated using a cloning cylinder, subcultured, and transferred onto uninfected Huh-7.5.1 cells. (A) Observation by
phase-contrast microscopy at 10 days of culture. (B) After 15 days of culture, the supernatant was transferred onto uninfected Huh-7.5.1 cells and an immunofluorescence
assaywas performed 5 days after infection using anti-core antibody. (C) Supernatants from parental JFH1, plaque-derived viruses (Pl #1, #2, and #3) and the second round
isolation of plaques from the Pl #1 subclones (Pl #1-1, #1-2, and #1-3) were inoculated onto Huh-7.5.1 cells with PFU-adjusted doses, respectively. HCV core antigen
levels in culture medium were measured on the days indicated. Inoculation and the assays were done in triplicate. The S.D.s were within 4% in each plot.
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and inhibits phosphorylation of eIF2-alpha at high levels of
expression (Pavio et al., 2003). These reports have shown that
HCV may induce ER stress and regulate subsequent intracel-
lular responses to promote its survival in hepatocytes. Consis-
tently with these reports, our findings that HCV-JFH1 induces
the expression of an ER chaperon protein and phosphorylation
of eIF2-alpha indicates that robust replication of HCV-JFH1
produces unfolded proteins in the ER, leading to activation of
ATF6 and stimulation of the transcription of ER chaperon
proteins to promote protein folding. HCV-JFH1-induced un-folded proteins also activate PERK, which phosphorylates eIF2-
alpha to inhibit the protein translation. Furthermore, the severe
ER stress finally activates apoptosis signaling pathways at the
early stage of viral infection. Although which HCV-JFH1 gene
product is involved in ER stress-mediated apoptosis is not
identified in our study, such proteins may contribute to the
regulation of ER stress signaling in the host cell that leads to
viral survival or cell death.
The plaque assay is often used to quantify virus infectious
titers by visualizing the viral-induced CPE. However, due to the
noncytopathic nature of HCVand the lack of highly permissive
Table 2
Nucleotide changes and amino acid substitutions in the cytopathic JFH1
subclone
Nucleotide a Amino acid a
A1353G M334V
C2842A T843K
G3402A G1017S
A5819G Synonymous
T7662A C2438S
C9153T P2934S
G9232A G2960D
G9293C Synonymous
G9295C R2985P
C9353A H3000Q
G9355A S3001N
a Nucleotide and amino acid numbers were derived from pJFH1full (Wakita
et al., 2005).
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on visualization of the infected focus by immunostaining HCV
proteins (Zhong et al., 2005). Disadvantages include the costs of
the antibodies and substrate, additional steps for assay and
detection, and microscopic examination to count the foci. By
using a highly permissive host cell line and optimizing several
conditions, we have developed a plaque assay for HCV.
Because the HCV-JFH1 strain is not absolutely cytopathic and
does not kill all infected cells, the calculated plaque-forming
units do not directly reflect HCV infectious titer but rather
reflect cytopathogenicity or the percentage of cytopathic clones
in the total infectious foci.
The HCV plaque assay revealed that JFH1 infection and
replication developed cytopathic and noncytopathic infectious
cell foci (Fig. 3B). One would suspect that the different
outcomes of HCV replication might be attributable to the clonal
heterogeneity of the host cells. However, there are several
pieces of evidence that the Huh-7.5.1 cell line, which we used as
host, might be a homogenous cell line. Huh-7.5.1 is derived
from parental Huh7 cells through two rounds of clonal selection
for neomycin resistance that were dependent on permissiveness
for the HCV subgenomic replicon (Blight et al., 2002; ZhongTable 3
Nucleotide changes and amino acid substitutions in the NS5B regions of the cytopa
Pl #1 #1-1 #1-2 #1-3
T7662A (C2438S) T7662A (C2438S) T7662A (C2438S) T7662A (C2
C9153T (P2934S) C9153T (P2934S) C9153T (P2934S) C9153T (P2
G9232A (G2960D)
G9295C (R2985P) G9295C (R2985P) G9295C (R
C9353A (H3000Q) C9353A (H3000Q)
G9355A (S3001N) G9355A (S3001N) G9355A (S3
Nucleotide and amino acid numbers were derived from pJFH1full (Wakita et al., 20et al., 2005). Sumpter et al. have reported that the HCV-
permissive feature is due to mutational inactivation of RIG-I, a
cytoplasmic double-stranded RNA sensor that induces type-I
IFN production (Sumpter et al., 2005). This evidence suggests
that the cytopathic HCV replication is attributable to virus
factors, in particular, virus genomic alteration and not by clonal
variation or evolution of the host cells.
Indeed, the isolation of the plaque-forming HCV subclones
and inoculation onto naive cells showed significantly higher
replication yields (Fig. 8) and more frequent development of
cytopathic plaques (Table 1). These findings indicate that HCV-
JFH1 has evolved into cytopathic and noncytopathic subclones.
Our results are similar to BVDV infection. BVDVis divided into
two biotypes, cytopathic (cp) and noncytopathic (ncp) strains.
Most cp strains, which induce strong apoptotic cell death upon
infection, develop from the ncp strains by RNA recombination
such as insertion of cellular sequences, duplications and
rearrangements, and deletions and lead to expression of the
NS3 protein (Meyers and Thiel, 1996). Kummerer et al. have
reported that other cp strain had point mutations in NS2 that
enhanced cleavage of NS2/3 junction and NS3 production
(Kummerer andMeyers, 2000). As for HCV, considering a rapid
HCV replication cycle and the poor fidelity of the viral NS5B
RNA-dependent RNA polymerase (RdRp) (Bartenschlager and
Lohmann, 2000; Kato et al., 2005), evolution of sequence
variants may well develop even after a transfection of cloned
HCV-RNA. Very recently, in vitro permissive subclones of HCV
genotype 1a, H77S stain, have been reported, which have five
cell culture-adaptive mutations in the NS3, 4A, and 5A regions
(Yi et al., 2007). In these clones, introduction of amino acid
substitutions in the p7 and NS2 region enhanced production of
the virion particles.
Interestingly, sequence analyses of a cytopathic HCV-JFH1
subclone (Pl #1) identified six amino acid substitutions in the
NS5B RdRp (Table 2). Three of the six mutations were re-
dundantly appeared in other clones that were independently
isolated from the plaques (Table 3). These findings make us
speculate that these amino acid substitutions may affect the
enzymatic activity of RdRp by altering tertiary structure of thethic JFH1 subclones
Pl #2 Pl #3 Pl #4
T7623A (S2428T)
438S) T7662A (C2438S) T7662A (C2438S)
A7550C
C7551A (N2470T)
G8259C
C8260G (A2640R)
934S) C9153T (P2934S)
G9162T (V2941L)
A9201T (I2954F)
G9235A (R2965Q)
2985P)
001N) G9355A (S3001N)
05).
Fig. 9. Introduction of various mutations into the NS5B region of JFH1. The mutations identified in the cytopathic plaque Pl #1; T7662A, C9153T, and G9295C were
introduced individually into the parental JFH1. Each JFH1 mutant, T7662A, C9153T, and G9295C, RNAwas transfected into Huh-7.5.1 cells by electroporation. The
transfected cells were split every 3 to 5 days (see Materials and methods). (A) JFH1 mutants transfected Huh-7.5.1 cells were observed by phase-contrast microscopy at
day 7 after transfection. (B) Levels of core antigen in the culture supernatants. The culture supernatants of transfected cells were collected on the days indicated, and the
levels of core antigen were measured. Asterisks indicate p-values of less than 0.05. (C) The supernatants of JFH1 mutants transfected Huh-7.5.1 cells were transferred
onto uninfected Huh-7.5.1 cells. The cells were harvested at 7 days after infection. Western blotting was performed using anti-core and anti-beta-actin.
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HCV replicase complex by altering surface affinity to other
nonstructural proteins. Mapping of the amino acid substitutions
in the RdRp tertiary structure has shown that the amino acid
2438 was located on the finger domain, and three amino acids,2934, 2960, and 2985, were located on the outer surface of the
thumb domain, which corresponds to the opposite side of the
nucleotide tunnel. The other substitutions, 3000 and 3001,
were within the domain of the polypeptide linking the poly-
merase to the membrane anchor (Lesburg et al., 1999). Very
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HCV-JFH1 of more than 60 days leads to the evolution of
certain mutations in the viral genome (Zhong et al., 2006).
They identified amino acid changes in Core, E2, NS3, and
NS5A regions, and especially E2 mutation increased infectivity
and density changes of viruses. In our present study, however,
we could not find those mutations in the virus subclones that
we have isolated in the plaque assay technique. The
discrepancy might be attributable to the presence or absence
of HCV-CPE-induced cell clonal alteration of the host Huh-
7.5.1 that occurs concomitantly with viral genetic evolution
during long-term cell culture. Further analyses may be
necessary to determine the most critical regions that regulate
the viral replication efficiency and cytopathogenicity.
Interestingly, the mutant virus clones, T7662A (C2438S),
C9153T (P2934S), and G9295C (R2985P), showed consider-
ably higher replication efficiency and cytopathogenicity than
the wild type JFH1 clone (Fig. 9). These results strongly suggest
that certain NS5B mutations in the plaque-purified strains
display more replication-efficient and cytopathic phenotypes.
The present data are still preliminary. Further studies may be
necessary to fully characterize these mutations and their func-
tions, which include introduction of mutations of the HCV
region and of the other plaque-purified viruses and combination
of the mutations, and to study their effects on virus protein
functions. We are at present analyzing derivative JFH1 clones in
which other amino acid mutations were introduced.
Several clinical findings have suggested that HCV is not
cytopathic and that antiviral immune responses such as cytotoxic
T lymphocytes play important roles in HCV pathogenesis
(Cerny and Chisari, 1999). On the other hand, apoptotic cell
death is the first cellular response to many hepatotoxic events
and has been implicated in the pathogenesis of liver diseases,
such as viral hepatitis, autoimmune diseases, alcohol-induced
injury, cholestasis, hepatocellular carcinoma, and fulminant
hepatic failure (Canbay et al., 2004; Ghavami et al., 2005; Patel
and Gores, 1995; Rodrigues et al., 2000; Rust and Gores, 2000;
Thompson, 1995). Several clinical studies have shown that
fulminant hepatic failure (FHF), from which HCV-JFH1 strain
was isolated, showed far more hepatocyte apoptosis, as
characterized by caspase activation and Fas-FasL expression,
than chronic hepatitis and normal populations (Leifeld et al.,
2006; Mita et al., 2005; Ryo et al., 2000). The ER stress markers
GRP78 and ATF6 are upregulated in the HCV liver tissue as the
histological grade advanced. In addition, GRP78 and ATF6 are
upregulated as the histological grade increased in hepatocellular
carcinoma (HCC) (Shuda et al., 2003) and proteomic analysis of
HCC tissue samples has shown significant upregulation of
HSP70 andGRP78 (Chuma et al., 2003; Takashima et al., 2003),
indicating that these proteins may play important roles in HCV-
induced hepatocarcinogenesis.
In conclusion, the cytopathic mutants of HCV-JFH1 strain
were isolated by using plaque assay techniques. A mechanism
of the cytopathic effects involved ER stress-mediated apoptosis
that was triggered by virus infection. That process of cytopathic
effects might explain one aspect of HCV-induced liver injury
during acute infection. Further analyses of cellular effects onHCV replication may elucidate the pathogenesis of HCV infec-
tion and may define novel host factors as targets of antiviral
chemotherapeutics.
Materials and methods
Reagents
Recombinant human interferon alpha-2b was from Schering-
Plough (Kenilworth, NJ). Beta-mercaptoethanol was from
Wako (Osaka, Japan). Anti-CD81 antibody (JS-81) was from
BD Biosciences (Franklin Lakes, NJ) (Morikawa et al., 2007).
Cells and cell culture
Huh-7.5.1 cells (Zhong et al., 2005) (kindly provided by
Dr Francis V. Chisari) were maintained in Dulbecco's modified
minimal essential medium (DMEM, Sigma) supplemented with
2 mmol/l L-glutamine and 10% fetal bovine serum at 37 °C
under 5.0% CO2.
In vitro RNA synthesis and transfection
A plasmid, pJFH1-full (Wakita et al., 2005), which encodes
the full-length HCV-JFH1 sequence, and two control plasmids
for pJFH1-full were used; pJFH1/GND that is a replication
incompetent mutant with a mutation in the NS5B GDD motif
and pJFH1/ΔE1-E2 in which a coding region of the HCV
envelope proteins was deleted. The HCV RNAwas synthesized
using the RiboMax Large Scale RNA Production System
(Promega, Madison, WI), with the linearized pJFH1 plasmid as
template. After DNaseI (RQ-1 RNase-free DNase, Promega)
treatment, the transcribed HCV-RNA was purified using
ISOGEN (Nippon Gene, Tokyo, Japan). For the RNA
transfection, Huh-7.5.1 cells were washed twice, and 5×106
cells were resuspended in Opti-MEM I (Invitrogen, Carlsbad,
CA) containing 10 μg of HCV RNA, transferred into a 4-mm
electroporation cuvette, and subjected to an electric pulse
(1050 μF and 270 V) using the Easy Ject system (EquiBio,
Mieddlesex, UK). After electroporation, the cell suspension was
left for 5 min at room temperature and then incubated under
normal culture conditions in a 10-cm diameter cell culture dish.
The transfected cells were split every 3 to 5 days. The culture
supernatants were subsequently transferred onto uninfected
Huh-7.5.1 cells. The levels of HCV replication and viral protein
expression were detected by real-time PCR, western blotting,
and immunocytochemistry.
HCV subgenomic replicon constructs
HCV subgenomic replicon plasmid pRep-Feo was derived
from the HCV-N strain pHCV1bneo-delS (Tanabe et al., 2004)
and pSGR-JFH1 was from the HCV-JFH1 strain (Kato et al.,
2003). The replicon RNA was synthesized from pRep-Feo or
pSGR-JFH1 and transfected into Huh-7.5.1 cells. After culture
in the presence of G418 (Wako), cell lines stably expressing the
replicon were established.
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Total cellular RNA was isolated using ISOGEN (Nippon
Gene). Two micrograms of total cellular RNA was used to
generate cDNA from each sample using SuperScript II
(Invitrogen) reverse transcriptase. Expression of mRNA was
quantified using Quanti Tect SYBR Green PCR Master Mix
(QIAGEN, Valencia, CA) and the ABI 7500 Real-Time PCR
System (Applied Biosystems, Foster City, CA). The primers
used were as follows: HCV-JFH1 sense (positions 7090 to 7109;
5′-TCA GAC AGA GCC TGA GTC CA-3′), HCV-JFH1
antisense (positions 7404 to 7423; 5′-AGT TGC TGG AGG
GCT TCT GA-3′), beta-actin sense (5′-ACA ATG AAG ATC
AAG ATC ATT GCT CCT CCT-3′), and beta-actin antisense
(5′-TTTGCGGTGGACGATGGAGGGGCCGGACTC-3′).
Quantification of HCV core antigen in the culture supernatant
The culture supernatants of JFH1-RNA transfected Huh-
7.5.1 cells were collected on the days indicated, passed through
a 0.45 μm filter (MILLEX-HA, Millipore, Bedford, MA), and
stored at −80 °C. The levels of core antigen in the culture
supernatants were measured using a chemiluminescence en-
zyme immunoassay (CLEIA) according to the manufacturer's
protocol (Lumipulse Ortho HCV Antigen, Ortho-Clinical
Diagnostics, Tokyo, Japan).
Western blotting
Western blotting was carried out as described previously
(Tanabe et al., 2004; Yokota et al., 2003). Briefly, 10 μg of total
cell lysate was separated by SDS–PAGE and blotted onto a
polyvinylidene fluoride (PVDF) western blotting membrane.
The membrane was incubated with the primary antibodies
followed by a peroxidase-labeled anti-IgG antibody and visu-
alized by chemiluminescence using the ECL western blotting
Analysis System (Amersham Biosciences, Buckinghamshire,
UK). The antibodies used were anti-core mouse monoclonal
antibody 2H9 (provided by Dr. Wakita), anti-GRP78 goat
monoclonal antibody, anti-GADD153/CHOP rabbit polyclonal
antibody (Santa Cruz Biotechnology, Santa Cruz, CA), anti-
eIF2-alpha, anti-phospho-eIF2-alpha rabbit polyclonal antibody
(Cell Signaling, Danvers, CA), and anti-beta-actin antibody
(Sigma).
Immunocytochemistry
HCV-JFH1-transfected or infected Huh-7.5.1 cells were
cultured in Lab-Tek® Chamber Slide™ (Nalge Nunc Interna-
tional, Rochester, NY) or on 22-mm-round micro cover glasses
(Matsunami, Tokyo, Japan). For detection of HCV-core and
GRP78, cells were fixed with cold acetone for 15 min. The cells
were incubated with the primary antibodies for 1 h at 37 °C and
with Alexa Fluor 488 goat anti-mouse IgG antibody or Alexa
Fluor 568 donkey anti-goat IgG antibody (Molecular Probes,
Eugene, OR) for 1 h at room temperature. To analyze apoptosis
of HCV-JFH1 infected cells, double staining for annexinV-FITCbinding and for cellular DNA using propidium iodide (PI) was
performed using an annexin V-Fluorescein Staining Kit (Wako,
Osaka, Japan). Cells were visualized by a fluorescence micros-
copy (BZ-8000, KEYENCE, Osaka, Japan).
Plaque assay
Huh-7.5.1 cells were seeded in collagen-coated 60-mm-
diameter plates at a density of 2–4×105 cells per plates and were
incubated at 37 °C under 5.0% CO2 (as described above). After
overnight incubation, HCV-infected culture supernatants were
serially diluted in a final volume of 2 ml per plates and
transferred onto the cell monolayers. After ∼5 h of incubation,
the inocula were removed, and the cell monolayers were overlaid
with 8 ml of culture medium (DMEM, 2mmol/l L-glutamine and
10% fetal bovine serum) that contained 0.8% methylcellulose.
After 7 to 12 days of incubation under normal culture conditions,
formation of cytopathic plaque was visualized by staining the
cell monolayers with 0.08% crystal violet solution (Sigma). The
levels of cytotoxicity were evaluated by counting the plaques
and calculating the titer (PFU/ml). Similarly, the titers of
infectivity were evaluated by performing immunocytochemistry
to detect foci of HCV-core-positive cells and calculating the
infectious focus-forming units (FFU/ml).
Sequence analyses
The cDNA from the isolated JFH1 plaque was amplified from
cytopathic virus-infected Huh-7.5.1 cells by RT-PCR and sub-
jected to direct sequence determination. Nucleotide sequences
were read from both strands using Big Dye Terminator Cycle
Sequencing Ready Reaction kits (Applied Biosystems) and an
automated DNA sequencer (ABI PRISM® 310 Genetic
Analyzer; Applied Biosystems).
Establishment of mutant JFH1 clones
In order to introduce various mutations into the NS5B region
of JFH1, plasmid pJFH1 was digested with HindIII and the
DNA fragment encompassing nt. 8231 to 9731 was subcloned
into the pBluescriptII SK+ phagemid vector (Stratagene, La
Jolla, CA). The following mutations were introduced into the
DNA fragment in the subcloning vector by site-directed
mutagenesis (Quick-ChangeII Site-Directed Mutagenesis Kit;
Stratagene): C9153T and G9295C, respectively. Finally, these
HindIII–HindIII fragments were subcloned back into the
parental plasmid pJFH1. The mutation T7662A-introduced
PCR fragment (nt. 7421–7839) was subcloned into the T-Vector
(pGEM-T Easy Vector Systems; Promega) and digested with
RsrII and BsrGI. Finally, these RsrII–BsrGI fragments were
subcloned back into the parental plasmid.
Statistical analyses
Statistical analyses were performed using the Student's t-test,
and p-values of less than 0.05 were considered as statistically
significant.
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